There have been many oncogenes pan-cancer analyses in recent years, such as SND1 [1], HER2 [2], and ARID1A [3] etc. These pan-cancer studies benefited from the publicly funded TCGA project and the accessible GEO database [4–6], which provide us with much convenience to perform pan-cancer analysis. The gene discussed is ERBB2; the disease is cancer.